Volume 5, Issue 2
Invited Opinion Articlep. 53-56
The value of extracellular miRNA in diabetic kidney disease
Author(s): Christos Argyropoulos, Yuanlin Ding, Kai Wang & Yuqing He
Editorialp. 57-61
Novo Nordisks Senior Vice President provides insight into diabetes care
Author(s): Alan Moses
Interviewp. 63-65
The diabetic foot: a core component of diabetes management
Author(s): Joanne McCardle
Research Articlep. 66-77
Self-reported frequency and impact of non-severe hypoglycemic events in insulin-treated diabetic patients in Denmark
Author(s): Marie Markert Jensen & Ulrik Pedersen-Bjergaard
Review Articlep. 79-87
Medication adherence and racial differences in diabetes in the USA: an update
Author(s): Alyce S Adams, Somalee Banerjee & Carolyn J Ku
Review Articlep. 89-101
Pharmacological cardioprotection in diabetes
Author(s): Idris Harding, Derek M Yellon & Robert M Bell
Review Articlep. 103-118
Islet autotransplantation: past, present and future. Chapter II: the role of islet autotransplantation for the treatment of chronic ancreatitis
Author(s): Elina Linetsky, Muyesser Sayki Arslan, Rodolfo Alejandro & Camillo Ricordi
Review Articlep. 119-125
Canagliflozin for Type 2 diabetes: an up-to-date evidence summary
Author(s): Aris Liakos, Thomas Karagiannis, Eleni Bekiari & Apostolos Tsapas
Review Articlep. 127-134
Insulin aspart for the treatment of Type 2 diabetes
Author(s): V Seshiah, Sanjay Kalra, Vijayam Balaji & Madhuri Balaji
